BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12460748)

  • 1. The effect of different tumor groupings on findings of anticarcinogenic responses in long-term rodent bioassays.
    Gray GM; Huang H; Linkov I; Polkanov M; Wilson R
    Regul Toxicol Pharmacol; 2002 Oct; 36(2):139-48. PubMed ID: 12460748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticarcinogenic responses in rodent cancer bioassays are not explained by random effects.
    Linkov I; Wilson R; Gray GM
    Toxicol Sci; 1998 May; 43(1):1-9. PubMed ID: 9629614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight and survival depression in rodent bioassays with and without tumor decreases.
    Linkov I; Wilson R; Gray GM
    Toxicol Sci; 1998 May; 43(1):10-8. PubMed ID: 9629615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monte Carlo simulation of rodent carcinogenicity bioassays.
    Shlyakhter A; Goodman G; Wilson R
    Risk Anal; 1992 Mar; 12(1):73-82. PubMed ID: 1574618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations among tumor types in mouse cancer bioassays: liver adenomas, liver carcinomas, leukemias and lymphomas.
    Linkov I; Polkanov M; Shagiakhmetov A; Wilson R; Gray GM
    Toxicol Ind Health; 2000 Jan; 16(1):16-40. PubMed ID: 10798383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of National Toxicology Program rodent bioassay data for anticarcinogenic effects.
    Haseman JK; Johnson FM
    Mutat Res; 1996 Feb; 350(1):131-41. PubMed ID: 8657174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Janus carcinogens and mutagens.
    von Borstel RC; Higgins JA
    Mutat Res; 1998 Jun; 402(1-2):321-9. PubMed ID: 9675327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioassays of shortened duration for drugs: statistical implications.
    Kodell RL; Lin KK; Thorn BT; Chen JJ
    Toxicol Sci; 2000 Jun; 55(2):415-32. PubMed ID: 10828275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 1/2. A multi-factor ranking scheme for comparing the carcinogenic activity of chemicals.
    Nesnow S
    Mutat Res; 1990 Sep; 239(2):83-115. PubMed ID: 2385240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimates of the proportion of chemicals that were carcinogenic or anticarcinogenic in bioassays conducted by the National Toxicology Program.
    Crump KS; Krewski D; Van Landingham C
    Environ Health Perspect; 1999 Jan; 107(1):83-8. PubMed ID: 9872721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How well can in vitro data predict in vivo effects of chemicals? Rodent carcinogenicity as a case study.
    Anthony Tony Cox L; Popken DA; Kaplan AM; Plunkett LM; Becker RA
    Regul Toxicol Pharmacol; 2016 Jun; 77():54-64. PubMed ID: 26879462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rodent carcinogenicity bioassay produces a similar frequency of tumor increases and decreases: implications for risk assessment.
    Davies TS; Monro A
    Regul Toxicol Pharmacol; 1994 Dec; 20(3 Pt 1):281-301. PubMed ID: 7724835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weighted p-value adjustments for animal carcinogenicity trend test.
    Chen JJ; Lin KK; Huque M; Arani RB
    Biometrics; 2000 Jun; 56(2):586-92. PubMed ID: 10877321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordance of carcinogenic response between rodent species: potency dependence and potential underestimation.
    Piegorsch WW; Carr GJ; Portier CJ; Hoel DG
    Risk Anal; 1992 Mar; 12(1):115-21. PubMed ID: 1574611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between use of the maximum tolerated dose and study sensitivity for detecting rodent carcinogenicity.
    Haseman JK; Lockhart A
    Fundam Appl Toxicol; 1994 Apr; 22(3):382-91. PubMed ID: 8050633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures.
    Ashby J; Paton D
    Mutat Res; 1993 Mar; 286(1):3-74. PubMed ID: 7678908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Dietary Restriction on Toxicology and Carcinogenesis Studies in F344/N Rats and B6C3F1 Mice.
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 Sep; 460():1-414. PubMed ID: 12587016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How many high production chemicals are rodent carcinogens? Why should we care? What do we need to do about it?
    Johnson FM
    Mutat Res; 2003 Jun; 543(3):201-15. PubMed ID: 12787813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.